Brice Chanez, Romain Appay, Arnaud Guille, Arnaud Lagarde, Carole Colin, José Adelaide, Emilie Denicolai, Carine Jiguet-Jiglaire, Céline Bequet, Thomas Graillon, Sébastien Boissonneau, Isabelle Nanni-Metellus, Henry Dufour, Dominique Figarella-Branger, Olivier Chinot, Emeline Tabouret
Journal of the neurological sciences 2022 May 15We aimed to identify genomic drivers of glioblastoma inevitable recurrence. Ten pairs of initial and recurrent frozen IDHwt glioblastoma samples were screened by CGH Array. Next Generation Sequencing (NGS) was then performed on an enriched cohort of 19 pairs. MPDZ alterations were analyzed using TCGA dataset. Nineteen IDHwt glioblastoma patients were included. Median age was 54.5 y/o (37.2-72.8). Using CGH array, unsupervised analysis aggregated the cohort by paired initial and recurrent tumors. Only 44% of CGH Array alterations were conserved at recurrence (amplifications: 55%; deletions: 30%). Two regions (including FPR1, 2 and 3) were lost at relapse: 19q13.33 and 19q13.41. MPDZ and 25 other genes were altered in ≥20% of recurrent tumors. NGS analysis of 29 candidate genes revealed 4 genes with pathogenic mutations: (FPR2, REL, TYRP1 and MPDZ). MPDZ (Multiple PDZ Domain Crumbs Cell Polarity Complex Component) was altered by two pathogenic mutations occurring at relapse. Using TCGA dataset we observed that a lower MPDZ mRNA expression was associated with IDHwt (p < 0.001) and grade IV (p < 0.001) gliomas. Finally, a low mRNA MPDZ expression was significantly correlated to poor overall survival in both IDHwt and IDH mutated gliomas, reinforcing the potential pejorative impact of MPDZ loss. Our results suggest that MPDZ is more frequently altered at relapse after radio-chemotherapy in glioblastoma IDHwt patients, suggesting that MPDZ impairment could contribute to the systematic resistance of these tumors opening new therapeutic perspectives. Copyright © 2022 Elsevier B.V. All rights reserved.
Brice Chanez, Romain Appay, Arnaud Guille, Arnaud Lagarde, Carole Colin, José Adelaide, Emilie Denicolai, Carine Jiguet-Jiglaire, Céline Bequet, Thomas Graillon, Sébastien Boissonneau, Isabelle Nanni-Metellus, Henry Dufour, Dominique Figarella-Branger, Olivier Chinot, Emeline Tabouret. Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy. Journal of the neurological sciences. 2022 May 15;436:120207
PMID: 35259554
View Full Text